doi: 10.1093/jnci/djn190
We have described a case in which the administration of orlistat produced a decrease in INR in patients on warfarin therapy
"Mayo Clinic" In addition, elevated circulating NETs and likely other extracellular chromatin derived from different cell types collaborate to worsen diabetic atherogenesis, putting patients at increased risk of insulin resistance, vasculitis, microclotting, disseminated intravascular coagulation, and occlusive intravascular prothrombotic ischemic events
Conflict of interest statement Within the last 36 months, FK has served on scientific advisory panels and/or been part of speaker's bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi and Zealand Pharma